Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.4250 (0.83%) ($2.4250 - $2.4250) on Fri. Apr. 22, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.93% (three month average) | RSI | 19 | Latest Price | $2.4250(0.83%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -1.6% a day on average for past five trading days. | Weekly Trend | CGEN declines -12% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) SPY(99%) IVE(98%) EWI(97%) IVW(97%) IWF(97%) | Factors Impacting CGEN price | CGEN will decline at least -1.965% in a week (0% probabilities). UNG(-49%) UUP(-13%) TIP(-12%) SHY(0%) TBT(2%) | | | | | Relative Volatility | | | | Market Trend Strength | -1.965% (StdDev 3.93%) | Hourly BBV | -0.4 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-18.02(-843.09%) | Resistance Level | $2.92 | 5 Day Moving Average | $2.5(-3%) | 10 Day Moving Average | $2.62(-7.44%) | 20 Day Moving Average | $2.92(-16.95%) | To recent high | -33.4% | To recent low | 0.8% | Market Cap | $201m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |